• Recent Articles

  • Sodexo awarded for ethics as workers make minimum wage
  • Who owns your genes?
  • Apologies
  • The Robber Barons of Social Change
  • Good Intentions
  • Toyota’s Tylenol moment
  • “Walking away” not immoral, prof says
  • How Will the Citizens United Decision Affect Sustainable Business?
  • UK Business schools put ethics high on MBA agenda
  • Does Kraft’s Takeover Mean the End of Cadbury’s Fair Trade Policies?
  • U.S. Attorney: Johnson & Johnson Paid Millions In Kickbacks To Boost Sales Of Schizophrenia Drug In Nursing Homes
  • With Tylenol recall 2010, a corporate icon stumbles

• Archives

  Select Month May 2010 April 2010 March 2010 February 2010 January 2010 December 2009 November 2009 October 2009 September 2009 August 2009 July 2009 June 2009 May 2009 March 2009 February 2009 January 2009 December 2008 November 2008 October 2008 September 2008 August 2008 July 2008 April 2008 January 2008 December 2007 October 2007 September 2007 August 2007 July 2007 June 2007 April 2007 February 2007 May 2006 January 2006 April 2005 March 2005 February 2005 January 2005

New York Times
Barry Meier
Read the article here.
Excerpt:

There is little question that battles over how much companies, doctors and medical institutions disclose about their financial ties will continue. But some experts on medical conflicts of interest, seeing the rapid fall of resistance by most major companies, say that a turning point has arrived.

“We are definitely moving toward more disclosure and disclosure of information that is useful to people,” said Lisa Bero, a pharmacy professor at the University of California, San Francisco.

Comments

Leave a Reply

Name (required)

Email Address(required)

Website

CAPTCHA Code

• Search for:

• Articles/Posts

  Articles
  Resources
  Academic Sites
  Audits/Reports
  Company Statements/Principles
  Organizations
  Other Business Ethics Sites
  SR Investments
  SR Job Resources
  Sustainability
  Tools

• Article Tag Cloud

  Pledges Corruption Compensation Essays/Papers/Presentations Sustainability SEC Company Audit Statements Legislation Transparency Reports Pharmaceuticals Investing Mortgages Fair Trade Censorship Scandals Sweatshops International Litigation Academia Greenwashing Shame Regulation Economics Banks Corporate Governance Corporate Personhood Business Ethics Bioethics Wall Street Philanthrocapitalism Obstructionists Jeff Stock Market

• Twitter Posts